PTC announced a multi‑year agreement with Hamilton Medical to replace its legacy application lifecycle management (ALM) system with Codebeamer, integrating the solution with PTC’s Windchill product lifecycle management (PLM) platform.
The partnership will give Hamilton Medical enhanced collaboration across engineering, risk, quality, and verification‑and‑validation teams, and create a unified product data foundation that links requirements, testing, and release decisions for end‑to‑end traceability.
The deal is a significant win for PTC in the regulated medical device sector, adding a high‑profile customer and reinforcing its strategy to embed AI and cloud‑native capabilities across its platform. It also supports PTC’s focus on market‑specific ALM‑PLM solutions for safety‑critical industries.
PTC’s Q1 2026 results showed a 21.4% revenue increase and an earnings per share of $1.92 versus an estimate of $1.42, a beat of $0.50. The company raised its FY'26 guidance, reflecting confidence in continued demand for its AI‑driven platform and the growing importance of compliance‑ready solutions.
Hamilton Medical’s Jim Giger said, “This collaboration positions us at the forefront of industry‑specific software development. Given the critical role our products play in patient care, our development processes must be both uncompromisingly rigorous and highly adaptable.” The quote underscores the importance of traceability and regulatory compliance in Hamilton’s product development.
By integrating Codebeamer with Windchill, PTC will provide Hamilton with a single source of truth for product data, enabling faster time‑to‑market while meeting stringent FDA and ISO requirements. The collaboration also allows PTC to refine its ALM‑PLM offering based on real‑world feedback from a leading medical device manufacturer.
The agreement is expected to generate recurring revenue for PTC and deepen its presence in a market where rapid innovation and rigorous compliance are critical. The partnership signals PTC’s continued expansion into regulated industries and its commitment to delivering end‑to‑end lifecycle solutions.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.